Reading USCB? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track USCB free→Reading USCB? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track USCB free→QuarterlyIQ Insights · USCB
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 3 valuation methods, at three horizons. Current price $19.55. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Peer P/E | 12M | $19.82 | 12.4 | 1.60 | TTM | high |
| PEG | 12M | $47.75 | 29.8 | 1.60 | TTM | high |
| triangulated | 12M | $20.38 | 12.4 | 1.65 | Triangulated | high |
| Peer P/E | 3Y | $36.63 | 12.4 | 2.96 | Analyst | medium |
| PEG | 3Y |
Monthly trailing P/E with quartile reference lines.
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
| $88.26 |
| 29.8 |
| 2.96 |
| Analyst |
| medium |
| Peer P/E | 5Y | $55.18 | 12.4 | 4.45 | Analyst | high |
| PEG | 5Y | $132.93 | 29.8 | 4.45 | Analyst | high |